A laboratory concentration-effect value depends partly on the system used to measure it.
What the study found
An electrophysiology study found midazolam inhibited expressed cardiac Kv1.5 currents. The estimated inhibitory concentration differed substantially between a cultured-cell system and frog oocytes, with experiments supporting open-channel block.
The experimental system changed the estimate
The reported half-inhibitory concentration was 17 micromolar in the HEK-cell system and 104 micromolar in Xenopus oocytes. Experiments were conducted at room temperature. Those differences matter when translating an isolated-channel result into intact human cardiac physiology. Neither number is a measured toxic blood threshold, and the net cardiac response also involves other currents and the clinical setting.
Limits of interpretation
The work did not directly measure the net electrical response of an intact human heart. Temperature, expression system, protein binding and tissue exposure complicate translation to clinical concentrations or arrhythmia risk.
Implications for case review
Identify the model and units before comparing a laboratory value with toxicology. Channel activity alone cannot establish that midazolam caused an individual arrhythmia or predict the shape of a patient’s ECG. Clinical timing, other drugs and cardiac disease remain necessary evidence.
Source and related reading
Source: PMC4232042, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Guggulsterone–Midazolam Interaction Findings Came From Experimental Systems.
Leave a Reply